PFIZER Company Profile

✉ Email this page to a colleague

PFIZER has one hundred and ninety-four approved drugs.

There are forty-eight US patents protecting PFIZER drugs. There is one tentative approval on PFIZER drugs.

There are one thousand and twenty-one patent family members on PFIZER drugs in seventy countries and two hundred and fifty-nine supplementary protection certificates in nineteen countries.

International Patents:	1021
US Patents:	48
Tradenames:	159
Ingredients:	130
NDAs:	194
Drug Master File Entries:	3
Patent Litigation for PFIZER:	See patent lawsuits for PFIZER
PTAB Cases with PFIZER as petitioner:	See PTAB cases with PFIZER as petitioner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Pfizer	CIBINQO	abrocitinib	TABLET;ORAL	213871-003	Jan 14, 2022		RX	Yes	Yes	9,035,074	⤷ Try a Trial	Y	Y		⤷ Try a Trial
Pfizer	DOXORUBICIN HYDROCHLORIDE	doxorubicin hydrochloride	INJECTABLE;INJECTION	050629-003	Mar 28, 2011		RX	Yes	No		⤷ Try a Trial				⤷ Try a Trial
Pfizer Inc	CAMPTOSAR	irinotecan hydrochloride	INJECTABLE;INJECTION	020571-003	Aug 5, 2010	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Pfizer	CLEOCIN PHOSPHATE	clindamycin phosphate	INJECTABLE;INJECTION	050441-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes		⤷ Try a Trial				⤷ Try a Trial
Pfizer	MEDROL	methylprednisolone	TABLET;ORAL	011153-004	Approved Prior to Jan 1, 1982	AB	RX	Yes	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Pfizer	COVERA-HS	verapamil hydrochloride	TABLET, EXTENDED RELEASE;ORAL	020552-001	Feb 26, 1996	5,082,668	⤷ Try a Trial
Pfizer	CYTOTEC	misoprostol	TABLET;ORAL	019268-003	Sep 21, 1990	4,301,146	⤷ Try a Trial
Pfizer	AROMASIN	exemestane	TABLET;ORAL	020753-001	Oct 21, 1999	4,904,650	⤷ Try a Trial
Pfizer	GLUCOTROL XL	glipizide	TABLET, EXTENDED RELEASE;ORAL	020329-002	Apr 26, 1994	5,591,454	⤷ Try a Trial
Pfizer	CYTOTEC	misoprostol	TABLET;ORAL	019268-001	Dec 27, 1988	4,060,691	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Delayed-release Tablets	50 mg/0.2 mg	➤ Subscribe	2009-06-29
➤ Subscribe	Extended-release Tablets	11 mg	➤ Subscribe	2016-11-07
➤ Subscribe	Capsules	20 mg, 40 mg, 60 mg and 80 mg	➤ Subscribe	2005-02-07
➤ Subscribe	Capsules	75 mg, 100 mg and 125 mg	➤ Subscribe	2019-02-04
➤ Subscribe	Capsules	0.125 mg, 0.25 mg, and 0.5 mg	➤ Subscribe	2014-05-01
➤ Subscribe	Tablets	600 mg	➤ Subscribe	2005-12-21
➤ Subscribe	Injection	2 mg/mL, 300 mL bag	➤ Subscribe	2009-09-01
➤ Subscribe	Tablets	1 g	➤ Subscribe	2005-08-23
➤ Subscribe	Delayed-release Tablets	75 mg/0.2 mg	➤ Subscribe	2008-11-28
➤ Subscribe	Extended-release Tablets	4 mg and 8 mg	➤ Subscribe	2012-10-31
➤ Subscribe	Injection	20 mg/mL, 2 mL and 5 mL vials	➤ Subscribe	2004-07-26
➤ Subscribe	Capsules	5 mg and 10 mg	➤ Subscribe	2005-06-21
➤ Subscribe	For Injection	500 mg/vial	➤ Subscribe	2011-06-17
➤ Subscribe	Oral Suspension	100 mg/5 mL	➤ Subscribe	2009-08-03
➤ Subscribe	Injection	2 mg/mL, 100 mL bag	➤ Subscribe	2009-12-29
➤ Subscribe	Tablets	5 mg	➤ Subscribe	2016-11-07

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Poland	218519	⤷ Try a Trial
Canada	2900322	⤷ Try a Trial
Nicaragua	200300008	⤷ Try a Trial
South Korea	20170081737	⤷ Try a Trial
Eurasian Patent Organization	006227	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2822953	2019034	Norway	⤷ Try a Trial	PRODUCT NAME: LORLATINIB; REG. NO/DATE: EU/1/19/1355 20190523
2767537	1990055-4	Sweden	⤷ Try a Trial	PRODUCT NAME: TALAZOPARIB, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REG. NO/DATE: EU/1/19/1377 20190624
0266730	98C0014	Belgium	⤷ Try a Trial	PRODUCT NAME: MIGLITOL; NAT. REGISTRATION NO/DATE: NL 22 138 19970204; FIRST REGISTRATION: NL - 19 343 UR 19960723
0139421	SPC/GB97/084	United Kingdom	⤷ Try a Trial	PRODUCT NAME: TROGLITAZONE, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: UK 10949/0277 19970729; UK 10949/0278 19970729; UK 10949/0279 19970729; UK 06384/0005 19970729; UK 06384/0006 19970729; UK 06384/0007 19970729
1470124	132017000046148	Italy	⤷ Try a Trial	PRODUCT NAME: PALBOCICLIB, OPZIONALMENTE NELLA FORMA DI UN SALE, ESTERE, AMMIDE O PROFARMACO FARMACEUTICAMENTE ACCETTABILE(IBRANCE); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/16/1147/001-006, 20161111
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.